This afternoon, the United States Supreme Court announced that it will hear the appeal in Association for Molecular Pathology v. Myriad Genetics on a single question: “Are human genes patentable?”
Continue reading Myriad Genetics going to the US Supreme Court →
The deadline for applying for the Canadian Patent Agent Exam is November 30, 2012. This is likely the last year for the patent agent exam under the current rules before new regulations applicable to the patent and trade-mark agent exams come into force.
Continue reading Patent Agent Exam →
Justice Létourneau of the Federal Court of Appeal is retiring and has tendered his resignation effective December 31, 2012.
Continue reading Justice Létourneau →
In a decision released Friday, the Federal Court of Appeal held that inventive concept is a question of law and application judges should look to determinations of inventive concept made in prior proceedings.
Continue reading Federal Court of Appeal on Inventive Concept →
Tomorrow is the one-year anniversary of the Federal Court of Appeal’s Amazon.com decision on patentable subject matter. There are reports that new CIPO Practice Notices on patentable subject matter will be issued after Christmas.
Continue reading Patentable Subject Matter →
In a decision released today, Justice Zinn held that the Federal Court had jurisdiction to consider Apotex’s impeachment action and motion for summary judgment and declared Pfizer’s patent on Viagra, Canadian Patent No. 2,163,466 invalid.
Continue reading Is the sildenafil patent invalid? →
For those interested in the copyright action started yesterday, T-2046-12, the action is a claim for restitution of past copyright tariff payments on ringtones paid by the plaintiffs to SOCAN.
Continue reading Rogers, Quebecor, Telus, Bell v. SOCAN →
A subcommittee of the Federal Courts Rules Committee has issued its report on a review of the rules. Some recommendations include revising Rule 3 to focus on resolution rather than ‘determination’, introducing ‘proportionality’ to the Rules, increasing available cost awards and formalizing Practice Notices.
Continue reading Review of Federal Courts Rules →
In a decision released today, the Supreme Court of Canada found Pfizer’s patent on sildenafil to be invalid for having an insufficient disclosure contrary to s.27(3) of the Patent Act.
Continue reading Supreme Court on Viagra →
Most of the amendments to the Copyright Act came into force today with publication in the Canada Gazette. Several sections, including those relating to notice-and-notice provisions for ISPs, are delayed for further regulations and the coming into force of treaties. Continue reading Copyright Act Amendments Enter Force →